MENU

Can Cerebras Systems (CBRS) Stock Reach $250?

A.I.Advisor
published price charts
A.I.Advisor
Nov 12, 2026

Can Cerebras Systems (CBRS) Stock Reach $250?

Key Takeaways

  • The central target of $250 used here is the arithmetic mean of recent, verifiable sell-side price targets from roughly eight firms, rounded from an underlying average near $248.
  • With Cerebras Systems (CBRS) trading around $97.75, reaching $250 would require a gain of roughly 156%, a very large move by any standard.
  • Individual 12-month analyst targets span a wide range, from about $178 to $325 (with a few earlier, since-cut targets near $340), reflecting sharp disagreement about the company's outlook.
  • The strongest supports are explosive AI-infrastructure revenue growth and a marquee customer relationship with OpenAI, while the biggest risks are widening losses, heavy customer concentration, and a sharp valuation reset in AI hardware.
  • Targets have been cut aggressively in recent weeks, yet nearly every analyst retains a Buy or Outperform rating even as the stock trades far below its $386.34 52-week high.
  • For more detail on the company's Major News, Today's Price Move, Forecast, and Earnings, explore the dedicated pages.
  • Readers can also explore Trending AI Robots to see AI-driven trading strategies currently in focus.

Analyst Price Targets and Consensus View

Cerebras Systems, Inc. is a Sunnyvale, California-based artificial intelligence infrastructure company best known for its wafer-scale engine (WSE) chips, which compete with GPU-based systems for AI inference and training workloads. Because it remains unprofitable, the stock is evaluated primarily on revenue growth, customer concentration, and its long-term technology roadmap rather than traditional earnings multiples.

Reviewing recent, attributed targets shows how much the Street's enthusiasm has cooled even as ratings stay bullish. Morgan Stanley's Joseph Moore kept an Overweight rating but cut his target to $178 from $279; Wedbush's Matt Bryson reiterated Outperform while lowering his target to $190 from $290; and UBS trimmed its target to $250 from $330. Other targets reviewed include Barclays at $280, Mizuho at $300, Needham at $300, Freedom Capital Markets at $209, and TD Cowen at $275. The arithmetic mean of these most recent figures is approximately $248, which rounds to the $250 central target used throughout this article.

The wide spread — roughly $178 to $325 — reflects genuine disagreement. Cautious analysts argue that valuation compression across AI hardware and questions about the longevity of the WSE architecture justify lower multiples, while more optimistic analysts point to a first-mover advantage in "fast inference" and a contracted pipeline that provides multi-year revenue visibility. This $250 figure is a calculated mean of individual targets, not an officially published consensus.

Current Market Position and Path Toward the Target

Shares closed at about $97.75, down sharply from a 52-week high of $386.34 reached in May 2026 but well above the $77.84 low touched in early November 2026. Reaching $250 would require an advance of roughly 156%, which qualifies as a very large move. The stock sits far below its 20-day and 60-day moving averages, indicating the near-term trend has been decisively lower despite a recent bounce.

The path toward a materially higher price would likely need to run through several milestones: continued triple-digit percentage revenue growth, evidence that the OpenAI relationship is expanding rather than merely stable, progress toward profitability or at least narrowing losses, and a stabilization in AI-hardware valuations after a sharp sector-wide reset.

What Could Support a Move Toward the Target

The core bull case rests on extraordinary top-line growth. Revenue in the company's most recent reported quarter rose roughly 74% year over year, and analysts continue to describe Cerebras as a leader in fast inference for agentic AI applications. A long-term agreement with OpenAI is central to the thesis, potentially insulating a meaningful portion of future revenue. A recent selection to power Bilt's AI platform, announced in November 2026, illustrates demand beyond the anchor customer. If execution on the next-generation CS-4 platform meets expectations and losses narrow, the valuation could re-rate upward.

What Could Prevent the Target From Being Reached

The obstacles are equally significant. The company is loss-making, with a wide GAAP net loss and negative EPS (earnings per share), meaning the stock carries no conventional earnings support at current levels. Revenue concentration in OpenAI is a double-edged sword, and analysts have explicitly flagged investor doubts about the durability of the WSE chips, depreciation practices, and the sustainability of data-center spending. A continued valuation reset in semiconductors, further guidance misses, or any sign of weakening demand for high-speed inference could keep the stock well below its former highs.

Technical Levels and Market Structure

From a technical standpoint, the $77–$78 zone, anchored by the November 2026 low, is the most important nearby support. The psychologically significant $100 level and the area near $108 (the 20-day moving average) represent near-term resistance, while the 60-day moving average near $160 marks a larger recovery hurdle. The stock remains in a long-term downtrend from its $386 peak, so any sustained move toward $250 would first require reclaiming these intermediate levels and establishing a durable base.

Time Horizon and What Investors Should Monitor

Analyst price targets generally reflect a research horizon of about 12 months, though the rapid pace of target revisions around the company shows how quickly those views can shift. Investors should watch quarterly earnings and guidance, any updates to the OpenAI agreement, progress on the CS-4 platform, new customer wins, and changes in analyst targets. Macroeconomic signals — particularly data-center capital spending and interest-rate policy from the Federal Reserve — also matter for a high-multiple, growth-oriented AI name.

AI Daily Buy/Sell Signals

Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile name like Cerebras, such tools can help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual chart review alone. Explore the signals to see how AI is currently reading this and other tickers.

Final Assessment

Reaching $250 from roughly $97.75 would require a gain of about 156%, a very large move that would demand sustained execution, an intact OpenAI relationship, and a meaningful recovery in AI-hardware sentiment. The central target reflects the mean of recent analyst targets that still sit far above the market price, underscoring the gap between Wall Street's long-term optimism and the market's current caution. Strong revenue growth and a leadership position in fast inference support the upside, while widening losses, customer concentration, and a brutal valuation reset weigh on the near term. The coming quarters of revenue, guidance, and analyst revisions will determine whether the stock can begin closing that gap.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Can Cerebras Systems (CBRS) Stock Reach $250?